From Asilomar to Genome Editing: Research Ethics and Models of Decision

被引:0
|
作者
Fabrizio Rufo
Antonella Ficorilli
机构
[1] Sapienza Università di Roma,Dipartimento di Biologia Ambientale
[2] Epidemiologia e Prevenzione “Giulio A. Maccacaro” Social Enterprise,undefined
来源
NanoEthics | 2019年 / 13卷
关键词
Asilomar conference; Genome editing; Democratic governance; Policy; Ethics; Social responsibility;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the presentation is to focus on the differences between two scientific contexts: the genetic engineering context of the 1970s, with specific attention paid to the use of the recombinant DNA technique to generate genetically modified molecules, and the current genome editing context, with specific attention paid to the use of CRISPR-Cas9 technology to modify human germ line cells genetically. In both events, scientists have been involved in discussions that have gone beyond mere professional deontology touching on specific policy issues such as freedom of research, responsibility for the consequences of research, the right of the public to participate in the evaluation of the goals of research methods, the relationship between cost and benefit and possible social consequences. The comparison between these two scientific contexts suggests the need of handling such issues by defining procedures that meet the criteria of democracy and responsibility towards society. The underlying objective should be to effectively launch actions and interventions based not on a hierarchical approach but rather a reticular conception of knowledge.
引用
收藏
页码:223 / 232
页数:9
相关论文
共 50 条
  • [31] Application of genome editing in cancer research
    Yamamoto, Takashi
    CANCER SCIENCE, 2018, 109 : 827 - 827
  • [32] Creation and Research of Cell Models of Hereditary Neurodegenerative Diseases Using Directed Genome Editing
    Medvedev, S. P.
    Malankhanova, T. B.
    Valetdinova, K. R.
    Zakian, S. M.
    NEUROCHEMICAL JOURNAL, 2021, 15 (04) : 353 - 358
  • [33] Creation and Research of Cell Models of Hereditary Neurodegenerative Diseases Using Directed Genome Editing
    S. P. Medvedev
    T. B. Malankhanova
    K. R. Valetdinova
    S. M. Zakian
    Neurochemical Journal, 2021, 15 : 353 - 358
  • [34] CRISPR-Cas9: from Genome Editing to Cancer Research
    Chen, Si
    Sun, Heng
    Miao, Kai
    Deng, Chu-Xia
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2016, 12 (12): : 1427 - 1436
  • [35] The ethics of creating genetically modified children using genome editing
    Ishii, Tetsuya
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2017, 24 (06) : 418 - 423
  • [36] The Ethics of Heritable Genome Editing New Considerations in a Controversial Area
    Adashi, Eli Y.
    Cohen, I. Glenn
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (24): : 2531 - 2532
  • [37] CELL MODELS OF CF CREATED BY GENOME EDITING
    Drumm, Mitchell L.
    Hao, Shuyu
    Henderson, Leigh C.
    Roesch, Erica
    Eastman, Jean
    PEDIATRIC PULMONOLOGY, 2014, 49 : 145 - 146
  • [38] Genome Editing 2020: Ethics and Human Rights in Germline Editing in Humans and Gene Drives in Mosquitoes
    Annas, George J.
    AMERICAN JOURNAL OF LAW & MEDICINE, 2020, 46 (2-3) : 143 - 165
  • [39] Basic course of genome editing for cancer research
    Ohmuraya, Masaki
    CANCER SCIENCE, 2018, 109 : 1208 - 1208
  • [40] Human genome editing: ensuring responsible research
    不详
    LANCET, 2023, 401 (10380): : 877 - 877